{"document": {"publication": "Tag My News", "full_text": "the brain infection risk from biogen idec's multiple sclerosis drug tysabri appears highest during the third year of treatment, u.s. health officials said in an updated warning released on friday.", "title": "fda details timeframe of ms drug tysabri's risks", "line_count": 1, "filename": "4737", "publication_date": "22-04-2011 20:48:54", "lines_and_colors": [["the brain infection risk from biogen idec's multiple sclerosis drug tysabri appears highest during the third year of treatment, u.s. health officials said in an updated warning released on friday.", {}]]}}